Archive Articles
Seed funding from Coulter Foundation is designed to accelerate nine promising projects.
Tracie Dinkins Receives the Staff Hero Award from the College of Engineering
AIMBE President Ravi Bellamkonda Briefs Congress on Brain Cancer Discoveries
BME undergrad caps banner year by studying abroad in Oxford program
SUSS MicroTec and the Georgia Institute of Technology (Georgia Tech) announced today a collaboration for nanotechnology, bio-medical andsemiconductor 3D packaging research.
College of Engineering Dean, Gary S. May, was in Washington, D.C. this week to receive his Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring (PAESMEM).
BME grad student going to research in Ireland thanks to GROW award
Entrepreneurial duo wins award for oral presentation in research symposium
Ravi Bellamkonda discusses biomedical engineering jobs on Georgia Public Broadcasting's radio show, On Second Thought.
Students from multiple disciplines going to work at UCB and Boston Scientific
Georgia Tech students design and build for children with disabilities
Newest core facility giving researchers unprecedented access to the brain
Yoganathan wins Standards Developer Award from the Association for the Advancement of Medical Instrumentation (AAMI).
The tumor monorail project, a collaboration between the Georgia Institute of Technology, Children’s Healthcare of Atlanta and Emory University, will receive a $6.5 million grant from The Marcus Foundation.
Coulter Department completes sweep for 2014-2015 school year
Ian’s Friends Foundation Recognizes Best Biomedical Engineering Senior Capstone Project Ideas
Application deadline February 2, 2015
Mark Prausnitz, a ChBE faculty member, has been elected a Fellow of the National Academy of Inventors (NAI). There are only 414 NAI Fellows worldwide.
Using molecular "hats," researchers have developed a way to sneak biomaterials containing the signaling molecules into living animals.
A new study has identified how one important gene helps cancer cells break free from the primary tumor.
The biosciences are big at Georgia Tech. Researchers discuss what’s happening and how they see the future.
Needles almost too small to be seen with the unaided eye could be the basis for new treatment options for two of the world’s leading eye diseases: glaucoma and corneal neovascularization.